Proceeding

Manuscript Reviewing Process.

1. Abstract Submission

The first step is abstract evaluation. A double blind examination by the Editor-in-Chief of Internal Reviewer will be conducted. The Reviewer first tests the abstract for the several criteria: subject scope, apparent scientific validity, topical importance, conciseness, and length.
The reviewer will decide whether the abstract will be accepted or not.

2. Full Manuscript Evaluation

The next step is manuscript evaluation. A double blind examination by two reviewers (external and internal) will be conducted. The reviewers are from the most direct
knowledge area of the subject matter and are expert reviewers in the field.

Each reviewer is asked to judge the technical validity of the manuscript and the extent of its advance beyond work previously published. The reviewer is asked also for advice concerning the specific merits and/or deficiencies of the manuscript. At the end, the decision to accept/reject/request for revision has to be provided by reviewer.

3. Revision or rebuttal

This step is subject to the choice of the author. If the paper has been rejected or if extensive revisions have been requested, but the author believes that the decsion is incorrect or unwarranted, he or she is entitled to submit a point-by-point rebuttal to the Editor’s statement of reasons and the reviewers’ comments. The rebuttal then is analyzed by the Editors, and a final decision is made, although there may be a need for an additional review cycle. Authors who revise their papers must make an effort to do so within the stated time period.
A reviewer who feels strongly that a particular paper should not be published may choose to write his or her criticism as a Comment. The author then will be allowed to write a closing response for publication in proceeding as the Comment.
Formal acceptance will not occur until the author has complied with all of the revision requests (if any) made by the Editor and has prepared the paper in the archival style. (Or
the Editor may accept the author’s rebuttal, as described above.)

4. Acceptance and Publication

When a paper is formally accepted, it will be scheduled for publication in a proceeding and
the author will be informed of the tentative date.
A file with galley proofs will be sent to authors for correction and release approximately two
weeks prior to publication. All authors and co-authors receive a complimentary electronic copy of the proceeding, in which their papers appear.

We accept full papers for publication in our 1st LUMMENS proceeding, that will be published by ScitePress, an open-access and Scopus-indexed proceeding.

Guideline for Full Paper:

1. Scope of the proceeding: Pharmacology, Pharmacy, Biomedical sciences, Clinical medicine, Dentistry, Nursing science, Public health science, Health policy, Psychology, and Medical education.
2. Abstract should be submitted first through this link, to be assessed by the reviewer.
3. After abstract acceptance, you will be invited to submit full paper using the form below.
4. The format of full paper should follow the ScitePress Guideline.
5. The deadline of full paper submission is 5 October 2019.
6. The full papers will be double-blinded peer-reviewed. Only the papers that satisfy the scope of the proceeding and quality requirements will be published.
7. The fee for proceeding publication will be announced later.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

NEWS UPDATE PER 11 SEPTEMBER 2019

Proceeding Process:

We invite you to submit a full paper to be published in the 1st LUMMENS proceeding. The
paper will be reviewed by 2 reviewers in a double-blind fashion. The author(s) will be notified for the decision, whether the manuscript is accepted, rejected, or needs revision.

When the paper has been thoroughly reviewed and formally accepted, it will be published in our serial LUMMENS proceedings, by SCITEPRESS publisher. Afterward, the publisher will submit the proceedings for indexation to Scopus or EI (Elsevier Engineering Village Index). All articles get a digital object identifier (DOI). If the paper is accepted and ready to be published, a publication fee will be requested from the Author(s).

1. Deadline for Full Paper submission to the LUMMENS Committee: 5 October 2019.
2. Main Conference date: 18-19 October 2019
3. Deadline for final version submission to SCITEPRESS: 18 January 2020.
4. Estimated publication date in SCITEPRESS Digital Library (Open Access): 20 April 2020.
5. SCITEPRESS will send the papers to the indexers (Scopus and EI): 20 April 2020.

Usually, it takes time for the indexers to grant approval to the indexation for papers. Guideline for Full Paper is here. The format of full-paper should follow the ScitePress Guideline (attached in the email). The deadline for full-paper submission is 5 October 2019.

Full-paper should be submitted by email to farmakologifk@ulm.ac.id
If you have questions, please do not hesitate to send them to the above email.